Cargando…
Local activation of cannabinoid CB(1 )receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
BACKGROUND: Systemic administration of cannabinoid agonists is known to reduce pain induced by bladder inflammation and to modulate cystometric parameters in vivo. We have previously reported that intravesical administration of a cannabinoid agonist reduces the electrical activity of bladder afferen...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115893/ https://www.ncbi.nlm.nih.gov/pubmed/21554718 http://dx.doi.org/10.1186/1744-8069-7-31 |